Wednesday, May 15, 2024
Home Tags ASX: AVR

Tag: ASX: AVR

Anteris marks first successful implantation of DurAVR THV heart valve

ASX-listed biotechnology company Anteris Technologies has announced the successful use of its DurAVR THV biomimetic valve in a valve-in-valve (ViV) procedure. 

Anteris awarded utility patent for novel transcatheter heart valve replacement

Australian biotechnology company Anteris Technologies announced that the US Patent and Trademark Office has issued another utility patent for its novel DurAVR transcatheter heart valve (THV).

Anteris Technologies to help develop new heart valve repair solution

Australian biotech company Anteris Technologies has collaborated with v2vmedtech to develop a new heart valve repair device designed for minimally invasive treatment of mitral and tricuspid valve regurgitation. 

Anteris granted utility patent for heart valve replacement technology

Australian biotechnology company Anteris Technologies announced that the United States Patent and Trademark Office has issued a utility patent for its novel DurAVR transcatheter heart valve (THV).

FDA OKs manufacturing of Anteris’ aortic valve replacement at Minnesota facility

Anteris Technologies announced that the US Food and Drug Administration (FDA) has approved the manufacturing of  DurAVR THV, a 3D single-piece aortic heart valve replacement, at the company's recently expanded production facility in Maple Grove, Minnesota.
Advertisement

Bits Orchestra

Manufacturing Catalyst

Featured Article

A business-led approach to maximising your SAP investment

Manufacturers are responding to the low-growth environment by focusing on digitisation, ESG and portfolio reshaping, transforming into more digital, resilient, and sustainable organisations.